Skip to main content
Equibles

XTX Topco Ltd

Position in NVS — Novartis AG

CIK 1828301 LONDON, X0
Back to NVS Full portfolio

Position in NVS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,762,786
-$7,488,670 QoQ
Shares Held
11,248
-81.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#461
of 1,609 holders
Holding Since
Dec 2021
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

XTX Topco Ltd holds $46,000,026 across 13 Drug Manufacturers - General names. NVS ranks #6 (3.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 PFE
Pfizer Inc
 834,735 $20,100,418
2 GILD
Gilead Sciences, Inc.
 68,150 $8,610,071
3 LLY
ELI LILLY & Co
 6,991 $8,385,215
4 NVO
Novo Nordisk A S
 48,420 $2,321,254
5 GSK
GSK plc
 35,304 $1,850,635
6 NVS
Novartis AG
This page 		11,248 $1,762,786
7 JNJ
Johnson & Johnson
 5,135 $1,304,135
8 BIIB
Biogen Inc.
 3,239 $699,818

All Filings in NVS

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,762,786 11,248
2026-03-31 $9,251,456 60,566
2025-12-31 $2,273,338 16,489
2025-09-30 $721,606 5,627
2025-06-30 $1,114,865 9,213
2025-03-31 $254,285 2,281
2024-12-31 $1,009,980 10,379
2024-09-30 $3,510,295 30,519
2023-12-31 $456,283 4,519
2022-09-30 $296,362 3,899
2021-12-31 $522,370 5,972